Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Monitoring imatinib resistance with a "polony" assay: towards tailored therapy of chronic myelogenous leukemia (CML)

Monitoring imatinib resistance with a "polony" assay: towards tailored therapy of chronic myelogenous leukemia (CML). Blood. 2006; 108:251a.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.